UPDATED May 28, 2022
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ESBKElmira Savings Bank | US$23.08 | 0.1% | 71.0% | US$82.1m | n/a | PB1.5x | n/a | 2.6% | Banks | ||
JOBS51job | US$60.90 | -0.05% | -15.2% | US$4.1b | US$57.25 | PS43.1x | S8.9% | n/a | Commercial Services | ||
RHDG.FRetail Holdings | US$0.43 | 0.2% | -4.2% | US$2.0m | n/a | PS4.1x | n/a | 0% | Retail | ||
VWTRVidler Water Resources | US$15.75 | 0.3% | 50.9% | US$288.2m | n/a | PS9.3x | n/a | n/a | Commercial Services | ||
APREAprea Therapeutics | US$0.96 | -18.4% | -77.1% | US$21.2m | US$3.00 | n/a | E32.4% | n/a | Pharmaceuticals & Biotech | ||
AMWLAmerican Well | US$3.86 | 26.6% | -69.0% | US$1.0b | US$4.89 | PS4x | E30.8% | n/a | Healthcare | ||
ASAASA Gold and Precious Metals | US$18.78 | 1.6% | -22.7% | US$362.2m | n/a | PS6.2x | n/a | 0.1% | Diversified Financials | ||
APPNAppian | US$50.01 | 3.9% | -44.7% | US$3.6b | US$57.33 | PS9.2x | E19.8% | n/a | Software | ||
ARTLArtelo Biosciences | US$0.34 | 4.1% | -72.2% | US$14.6m | US$3.08 | PS-1.2x | E-11.5% | n/a | Pharmaceuticals & Biotech | ||
AROWArrow Financial | US$33.25 | 5.3% | -7.7% | US$532.6m | US$33.00 | PB1.5x | E4.1% | 3.2% | Banks | ||
ASWR.FGungnir Resources | US$0.084 | 4.0% | 56.2% | US$10.0m | n/a | PB3.3x | n/a | n/a | Materials | ||
ASTRAstra Space | US$2.47 | -5.4% | -75.5% | US$652.5m | US$4.35 | PS166.9x | E10.5% | n/a | Capital Goods | ||
AMATApplied Materials | US$119.48 | 12.2% | -13.5% | US$103.9b | US$146.67 | PS15.4x | E6.8% | 0.9% | Semiconductors | ||
AQBAquaBounty Technologies | US$1.49 | 12.9% | -72.6% | US$106.0m | US$5.88 | PS51.4x | E-4.0% | n/a | Pharmaceuticals & Biotech | ||
AORE.FAmerican Overseas Group | US$190.01 | 0% | n/a | US$8.9m | n/a | PS-1.6x | n/a | n/a | Insurance | ||
ANTXAN2 Therapeutics | US$14.59 | 40.3% | n/a | US$283.1m | US$24.67 | PB2.5x | E-8.8% | n/a | Pharmaceuticals & Biotech | ||
ANIKAnika Therapeutics | US$22.05 | 5.1% | -52.7% | US$320.7m | US$37.50 | PS2.1x | E109.3% | n/a | Pharmaceuticals & Biotech | ||
CASHMeta Financial Group | US$41.60 | 12.6% | -21.5% | US$1.2b | US$71.00 | PB1.6x | E6.0% | 0.5% | Banks | ||
CARECarter Bankshares | US$15.00 | 5.3% | -3.7% | US$368.7m | US$19.33 | PB1x | E11.6% | 0% | Banks | ||
CBCZComunibanc | US$54.00 | 0% | 85.4% | US$44.7m | n/a | PB1.4x | n/a | 1.5% | Banks | ||
CAPRCapricor Therapeutics | US$3.64 | 4.6% | -4.0% | US$88.5m | US$15.00 | PS433.8x | E-16.6% | n/a | Pharmaceuticals & Biotech | ||
BYByline Bancorp | US$24.87 | 4.8% | 7.8% | US$940.0m | US$28.40 | PB1.2x | E-1.0% | 1.4% | Banks | ||
BMRCBank of Marin Bancorp | US$33.24 | 6.5% | -1.4% | US$529.7m | US$36.80 | PB1.3x | E11.2% | 2.9% | Banks | ||
BBSIBarrett Business Services | US$74.23 | 4.4% | -0.3% | US$543.4m | US$109.33 | PS12.7x | E8.8% | 1.6% | Commercial Services |